Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Infection|May 1, 1992
Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patientsM Jerkeman, J H Braconier
European Journal of Haematology|August 4, 2004
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experienceM Jerkeman, S Leppä, S Kvaløy, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2000
Residual mass in aggressive lymphoma--does size, measured by computed tomography, influence clinical outcome?M Rodriguez-Catarino, M Jerkeman, H Ahlström, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group TrialM Jerkeman, S Kaasa, M Hjermstad, et al.
British Journal of Cancer|February 13, 2001
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOPA Messori, M Vaiani, S Trippoli, et al.
Journal of Internal Medicine|March 16, 2017
Targeting of B-cell receptor signalling in B-cell malignanciesM Jerkeman, M Hallek, M Dreyling, et al.
Annals of Hematology|April 16, 2004
Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group studyM Jerkeman, H Anderson, M Dictor, et al.
European Journal of Haematology|March 25, 1999
Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomasM Jerkeman, B Johansson, M Akerman, et al.
International Journal of Oncology|December 18, 2001
Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group studyM Jerkeman, P Aman, E Cavallin-Stahl, et al.
Journal of Internal Medicine|October 29, 2018
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register studyT Wästerlid, M Mohammadi, K E Smedby, et al.
Pageof 2